About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Chapters
Books
News
Editorials
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Scientometrics
Impact Factor
Discipline Ranks
H-Index
G-Index
Articles
Citations
Article Citations
Citation Distribution
Search This Journal
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
exaly
›
Journals
›
Expert Opinion on Therapeutic Patents
›
Top Articles
Expert Opinion on Therapeutic Patents
Pharmacology
6.8
(top 2%)
Impact Factor
7.2
(top 2%)
extended IF
75
(top 5%)
H-Index
1.2K
authors
2.6K
papers
43K
citations
3.7K
citing journals
31.6K
citing authors
Most Cited Articles of Expert Opinion on Therapeutic Patents
Title
Year
Citations
Carbonic anhydrase inhibitors and their therapeutic potential
2000
432
Antiglaucoma carbonic anhydrase inhibitors: a patent review
2013
232
Applications of carbonic anhydrase inhibitors and activators in therapy
2002
228
Diuretics with carbonic anhydrase inhibitory action: a patent and literature review (2005 - 2013)
2013
218
Antiobesity carbonic anhydrase inhibitors: a literature and patent review
2013
213
Anticancer carbonic anhydrase inhibitors: a patent review (2008 - 2013)
2013
208
Anti-infective carbonic anhydrase inhibitors: a patent and literature review
2013
192
Sulfonamides: a patent review (2008 - 2012)
2012
167
Anticonvulsant/antiepileptic carbonic anhydrase inhibitors: a patent review
2013
150
Modulation of carbonic anhydrase activity and its applications in therapy
2004
148
Recent developments in CCR2 antagonists
2009
143
Carbonic anhydrase inhibitors and activators and their use in therapy
2006
143
5-Lipoxygenase inhibitors: a review of recent developments and patents
2010
139
Carbonic anhydrase inhibitors in the treatment and prophylaxis of obesity
2003
135
Sirtuin activators
2009
133
Recent advances in therapeutic chalcones
2004
132
The Development of Novel Therapies for Rheumatoid Arthritis
2008
129
GPR119 agonists for the treatment of type 2 diabetes
2009
125
Coumarin-based drugs: a patent review (2008 -- present)
2012
123
Carbonic anhydrase inhibitors as antitumor/antimetastatic agents: a patent review (2008-2018)
2018
121
Taxane anticancer agents: a patent perspective
2016
119
Urease inhibitors as potential drugs for gastric and urinary tract infections: a patent review
2011
118
Biodegradable thermosensitive copolymer hydrogels for drug delivery
2007
116
Schiff bases in medicinal chemistry: a patent review (2010-2015)
2017
112
Discovery and development of antimitotic agents that inhibit tubulin polymerisation for the treatment of cancer
2002
112
previous
2013
2014
2015
How are inpact factors calculated?
The impact factor (IF) is calculated by counting citations from peer-reviewed journals only.
extended IF
also counts citations from books and conference papers. However, no patent, abstract, working papers, online documents, etc., are covered.
site/software ©
exaly
; All materials licenced under
CC by-SA
.